ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 142 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $589 | -3.0% | 23,037 | +8.8% | 0.01% | +20.0% |
Q2 2023 | $607 | -16.0% | 21,176 | -29.8% | 0.01% | -16.7% |
Q1 2023 | $723 | +42.9% | 30,164 | +1.2% | 0.01% | -14.3% |
Q4 2022 | $506 | -99.9% | 29,816 | -37.3% | 0.01% | -22.2% |
Q3 2022 | $705,000 | -32.7% | 47,552 | +116.8% | 0.01% | -35.7% |
Q3 2021 | $1,048,000 | +3.7% | 21,937 | -5.9% | 0.01% | +40.0% |
Q4 2020 | $1,011,000 | -36.4% | 23,302 | -37.1% | 0.01% | -68.8% |
Q3 2020 | $1,590,000 | +1214.0% | 37,055 | +232.8% | 0.03% | +1500.0% |
Q4 2019 | $121,000 | – | 11,135 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Green Alpha Advisors, LLC | 8,394 | $264,663 | 0.19% |
Global Wealth Strategies & Associates | 100 | $3,153 | 0.00% |